Cisplatin and the sensitive cell

被引:6
作者
Bagby, GC [1 ]
Olson, SB [1 ]
机构
[1] Oregon Hlth & Sci Univ, Sch Med, OSHU Canc Inst, Portland, OR 97201 USA
关键词
D O I
10.1038/nm0503-513
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetic suppression of FANCF, a member of the Fanconi anemia gene family, is now implicated in some ovarian cancers. Might this suppression explain the sensitivity of such cancers to the cross-linking agent cisplatin (pages 568–574)?
引用
收藏
页码:513 / 514
页数:3
相关论文
共 9 条
[1]   Genetic basis of Fanconi anemia [J].
Bagby, GC .
CURRENT OPINION IN HEMATOLOGY, 2003, 10 (01) :68-76
[2]   The Fanconi anaemia BRCA pathway [J].
D'Andrea, AD ;
Grompe, M .
NATURE REVIEWS CANCER, 2003, 3 (01) :23-34
[3]   Biallelic inactivation of BRCA2 in Fanconi anemia [J].
Howlett, NG ;
Taniguchi, T ;
Olson, S ;
Cox, B ;
Waisfisz, Q ;
de Die-Smulders, C ;
Persky, N ;
Grompe, M ;
Joenje, H ;
Pals, G ;
Ikeda, H ;
Fox, EA ;
D'Andrea, AD .
SCIENCE, 2002, 297 (5581) :606-609
[4]  
LENSCH MW, IN PRESS BLOOD
[5]   Interaction of FANCD2 and NBS1 in the DNA damage response [J].
Nakanishi, K ;
Taniguchi, T ;
Ranganathan, V ;
New, HV ;
Moreau, LA ;
Stotsky, M ;
Mathew, CG ;
Kastan, MB ;
Weaver, DT ;
D'Andrea, AD .
NATURE CELL BIOLOGY, 2002, 4 (12) :913-920
[6]   The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC [J].
Pang, QS ;
Christianson, TA ;
Keeble, W ;
Koretsky, T ;
Bagby, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49638-49643
[7]   Insights into DNA recombination from the structure of a RAD51-BRCA2 complex [J].
Pellegrini, L ;
Yu, DS ;
Lo, T ;
Anand, S ;
Lee, M ;
Blundell, TL ;
Venkitaraman, AR .
NATURE, 2002, 420 (6913) :287-293
[8]   A novel diagnostic screen for defects in the Fanconi anemia pathway [J].
Shimamura, A ;
Oca, RMC ;
Svenson, JL ;
Haining, N ;
Moreau, LA ;
Nathan, DG ;
D'Andrea, AD .
BLOOD, 2002, 100 (13) :4649-4654
[9]   Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors [J].
Taniguchi, T ;
Tischkowitz, M ;
Ameziane, N ;
Hodgson, SV ;
Mathew, CG ;
Joenje, H ;
Mok, SC ;
D'Andrea, AD .
NATURE MEDICINE, 2003, 9 (05) :568-574